ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.
CANBERRA, Australia, Nov. 29 (UPI) -- Australian Prime Minister John Howard has announced a $342 million cervical cancer vaccination program.
WHITEHOUSE STATION, N.J., Nov. 1 (UPI) -- Merck said Wednesday the U.S. Centers for Disease Control and Prevention added Gardasil to its Vaccines for Children program.
WHITEHOUSE STATION, N.J., Sept. 22 (UPI) -- Merck said Friday the European Commission approved its cervical cancer vaccine Gardasil for use in children and adults.
PHOENIX, Aug. 1 (UPI) -- Blue Cross Blue Shield of Arizona (BCBSAZ) said Tuesday it would cover Merck's recently approved cervical cancer vaccine Gardisil.
WASHINGTON, June 8 (UPI) -- The U.S. Food and Drug Administration licensed a vaccine Thursday against a virus linked to cervical cancer.
WHITE HOUSE STATION, N.J., Feb. 7 (UPI) -- Merck said Tuesday its cervical cancer vaccine Gardasil has been granted priority review.
LYON, France, Dec. 13 (UPI) -- A vaccine to battle cervical cancer, which claims thousands of women's lives annually, could be available in Europe within a year, a report said Tuesday.
NEW YORK, April 7 (UPI) -- A new experimental vaccine can reduce the risk of cervical cancer by 90 percent, a study says.
LONDON, Oct. 29 (UPI) -- British researchers say a vaccine against cervical cancer could be available within three years, the BBC reported Friday.
